Bacillus amyloliquefaciens SC06 alleviated intestinal damage induced by inflammatory via modulating intestinal microbiota and intestinal stem cell proliferation and differentiation.
- 2024-03
- International immunopharmacology 130
- Qi Wang
- Fei Wang
- Li Tang
- Yang Wang
- Yuanhao Zhou
- Xiang Li
- Mingliang Jin
- Aikun Fu
- Weifen Li
- PubMed: 38377852
- DOI: 10.1016/j.intimp.2024.111675
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Population
- Twelve piglets (male, 21 days old, 6.11 ± 0.12 kg)
- Methods
- Randomly allocated to CON and SC06 (1 × 10^8 cfu/kg to diet) groups
- Duration
- three weeks
- Animal Study
The aim of our research was to investigate the effects of Bacillus amyloliquefaciens SC06 on growth performance, immune status, intestinal stem cells (ISC) proliferation and differentiation, and gut microbiota in weaned piglets. Twelve piglets (male, 21 days old, 6.11 ± 0.12 kg) were randomly allocated to CON and SC06 (1 × 108 cfu/kg to diet) groups. This experiment lasted three weeks. Our results showed that SC06 increased (P < 0.05) growth performance and reduced the diarrhea rate in weaned piglets. In addition, SC06 increased intestinal morphology and interleukin (IL)-10 levels, and decreased (P < 0.01) necrosis factor (TNF-α) levels in jejunum and serum. Moreover, weaning piglets fed SC06 had a better balance of colonic microbiota, with an increase in the abundance of Lactobacillus. Furthermore, SC06 enhanced ISCs proliferation and induced its differentiation to goblet cells via activating wnt/β-catenin pathway in weaned piglets and intestinal organoid. Taken together, SC06 supplementation improved the growth performance and decreased inflammatory response of piglets by modulating intestinal microbiota, thereby accelerating ISC proliferation and differentiation and promoting epithelial barrier healing.